426 related articles for article (PubMed ID: 33658393)
1. Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.
Shen E; Han Y; Cai C; Liu P; Chen Y; Gao L; Huang Q; Shen H; Zeng S; He M
Aging (Albany NY); 2021 Mar; 13(5):7570-7588. PubMed ID: 33658393
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
4. GREB1L overexpression correlates with prognosis and immune cell infiltration in lung adenocarcinoma.
Yu Y; Wang Z; Zheng Q; Li J
Sci Rep; 2021 Jun; 11(1):13281. PubMed ID: 34168239
[TBL] [Abstract][Full Text] [Related]
5. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
6. CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma.
He M; Han Y; Cai C; Liu P; Chen Y; Shen H; Xu X; Zeng S
J Cell Mol Med; 2021 Apr; 25(7):3391-3399. PubMed ID: 33655701
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
Pan Y; Sha Y; Wang H; Zhuang H; Ren X; Zhu X; Wei X
J Cancer Res Ther; 2020; 16(2):320-326. PubMed ID: 32474519
[TBL] [Abstract][Full Text] [Related]
8. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Fang L; Yu W; Yu G; Zhong F; Ye B
Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089
[TBL] [Abstract][Full Text] [Related]
9. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
Aizemaiti R; Wu Z; Tang J; Yan H; Lv X
Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814
[TBL] [Abstract][Full Text] [Related]
10. The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma.
Ren S; Wang W; Zhang C; Sun Y; Sun M; Wang Y; Zhang X; Lu B; Yao L
Cancer Med; 2021 May; 10(10):3403-3412. PubMed ID: 33934535
[TBL] [Abstract][Full Text] [Related]
11. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma.
Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H
J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169
[TBL] [Abstract][Full Text] [Related]
12. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
[TBL] [Abstract][Full Text] [Related]
14. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J
Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526
[TBL] [Abstract][Full Text] [Related]
15. NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma.
Yan Y; Gao Z; Han H; Zhao Y; Zhang Y; Ma X; Chen H
J Cancer Res Clin Oncol; 2022 Mar; 148(3):565-575. PubMed ID: 34746975
[TBL] [Abstract][Full Text] [Related]
16. GTSE1: A potential prognostic and diagnostic biomarker in various tumors including lung adenocarcinoma.
Yan G; Li G; Gao X; Liu J; Li Y; Li J; Zhou H
Clin Respir J; 2024 May; 18(5):e13757. PubMed ID: 38715380
[TBL] [Abstract][Full Text] [Related]
17. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.
Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H
Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836
[TBL] [Abstract][Full Text] [Related]
18. Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma.
Ma W; Liang J; Mo J; Zhang S; Hu N; Tian D; Chen Z
BMC Cancer; 2021 Oct; 21(1):1096. PubMed ID: 34635082
[TBL] [Abstract][Full Text] [Related]
19. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis.
Zhang W; Wan S; Qu Z; Ge J; Zhang C; Li C; Jiang Y
Medicine (Baltimore); 2022 Jul; 101(29):e29710. PubMed ID: 35866781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
